| Project/Area Number |
13671055
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Single-year Grants |
|---|
| Section | 一般 |
|---|
| Research Field |
Hematology
|
|---|
| Research Institution | Faculty of Medicine, University of Yamanashi |
|---|
Principal Investigator |
OZAKI Yukio University of Yamanashi, Faculty of Medicine, Professor, 医学部, 教授 (30134539)
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
SATOH Kaneo University of Yamanashi, Faculty of Medicine, Research Assistant, 医学部, 教務職員 (20242662)
ASAZUMA Naoki University of Yamanashi, Faculty of Medicine, Research Associate, 医学部, 助手 (60293445)
|
|---|
| Project Period (FY) |
2001 – 2002
|
| Project Status |
Completed (Fiscal Year 2002)
|
| Budget Amount *help |
¥4,000,000 (Direct Cost: ¥4,000,000)
Fiscal Year 2002: ¥1,000,000 (Direct Cost: ¥1,000,000)
Fiscal Year 2001: ¥3,000,000 (Direct Cost: ¥3,000,000)
|
|---|
| Keywords | Platelets / fibrinogen / GPIIb / IIIa / GPR peptide / platelet aggregation / surface plasmon resonance / 血小板疑集 / 凝集阻害 / フィブリノーゲン |
|---|
| Research Abstract |
We found that some collagen-derived peptides containing the GPR sequence inhibited not only collagen-induced platelet aggregation but also that induced by other agonists of platelet activation. The GPR-containing peptides are closely related to the structure of fibrinopeptide A-cleaved fibrinogen end, while it does not bind to fibrinogen itself. Several lines of evidence suggest that these peptides interact with GPIIb/IIIa. However, unlike RGD peptides, they do not have partial agonist effects on GPIIb/IIIa. In order to prove that these peptides interact with GPIIb/IIIa, we purified GPIIb/IIIa from intact platelets, using ConA affinity columns and fixed them onto a tip for the measurement of surface plasmon resonance. Fibrinogen in this system bound to GPIIb/IIIa with the expected affinity constant. However, we were able to demonstrate the inhibitory effect of these GPR-containing peptides on the interaction between GPIIb/IIIa and fibrinogen, the binding between GPIIb/IIIa and these GPR-containing peptides. On the other hand, the biotinylated peptide, fixed to the tip in this system, interacted with GPIIb/IIIa albeit to a small extent. The discrepancy implies that GPIIb/IIIa during the purification procedures may have undergone changes, and have properties distinct from native GPIIb/IIIa. In order to address this issue, GPIIb/IIIa was transfected into CHO cells, and the effects of the GPR-containing peptides on fibrinogen binding to GPIIb/IIIa or their direct binding to GPIIb/IIIa was evaluated. However, we were able to demonstrate the interaction between GPIIb/IIIa and the GPR-containing peptides. Thus, in contrast to our original expectation, it is suggested that the GPR-containing peptides do not interact with GPIIb/IIIa.
|
